147 related articles for article (PubMed ID: 30249885)
1. Association of serum annexin A1 with treatment response and prognosis in patients with esophageal squamous cell carcinoma.
Han GH; Lu KJ; Huang JX; Zhang LX; Dai SB; Dai CL
J Cancer Res Ther; 2018 Sep; 14(Supplement):S667-S674. PubMed ID: 30249885
[TBL] [Abstract][Full Text] [Related]
2. Effect of Annexin A1 gene on the proliferation and invasion of esophageal squamous cell carcinoma cells and its regulatory mechanisms.
Han G; Lu K; Huang J; Ye J; Dai S; Ye Y; Zhang L
Int J Mol Med; 2017 Feb; 39(2):357-363. PubMed ID: 28035369
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers.
Luthra R; Singh RR; Luthra MG; Li YX; Hannah C; Romans AM; Barkoh BA; Chen SS; Ensor J; Maru DM; Broaddus RR; Rashid A; Albarracin CT
Oncogene; 2008 Nov; 27(52):6667-78. PubMed ID: 18663355
[TBL] [Abstract][Full Text] [Related]
4. miR-196a regulates the proliferation, invasion and migration of esophageal squamous carcinoma cells by targeting ANXA1.
Hu C; Peng J; Lv L; Wang X; Zhou Y; Huo J; Liu D
Oncol Lett; 2019 Jun; 17(6):5201-5209. PubMed ID: 31186736
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-196a promotes an oncogenic effect in head and neck cancer cells by suppressing annexin A1 and enhancing radioresistance.
Suh YE; Raulf N; Gäken J; Lawler K; Urbano TG; Bullenkamp J; Gobeil S; Huot J; Odell E; Tavassoli M
Int J Cancer; 2015 Sep; 137(5):1021-34. PubMed ID: 25523631
[TBL] [Abstract][Full Text] [Related]
6. Serum microRNA-15a level acts as a potential diagnostic and prognostic biomarker for human esophageal squamous cell carcinoma.
Li J; Li M; Gao F; Ge X
Cancer Biomark; 2017; 18(1):11-17. PubMed ID: 27802201
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma.
Wu C; Li M; Hu C; Duan H
Mol Biol Rep; 2014 Mar; 41(3):1257-66. PubMed ID: 24390317
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
9. MiR-613: a novel diagnostic and prognostic biomarker for patients with esophageal squamous cell carcinoma.
Guan S; Wang C; Chen X; Liu B; Tan B; Liu F; Wang D; Han L; Wang L; Huang X; Wang J; Yao B; Shi J; Chen P; Nesa EU; Song Q; Cheng Y
Tumour Biol; 2016 Apr; 37(4):4383-91. PubMed ID: 26499784
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic and predictive significance of serum microRNA-7 in esophageal squamous cell carcinoma.
Dong W; Li B; Wang J; Song Y; Zhang Z; Fu C; Zhang P
Oncol Rep; 2016 Mar; 35(3):1449-56. PubMed ID: 26708917
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b.
Álvarez-Teijeiro S; Menéndez ST; Villaronga MÁ; Pena-Alonso E; Rodrigo JP; Morgan RO; Granda-Díaz R; Salom C; Fernandez MP; García-Pedrero JM
Sci Rep; 2017 Jul; 7(1):6790. PubMed ID: 28754915
[TBL] [Abstract][Full Text] [Related]
12. Association of nuclear annexin A1 with prognosis of patients with esophageal squamous cell carcinoma.
Han G; Tian Y; Duan B; Sheng H; Gao H; Huang J
Int J Clin Exp Pathol; 2014; 7(2):751-9. PubMed ID: 24551299
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of miR-138 predicts poor prognosis in patients with esophageal squamous cell carcinoma.
Zheng S; Zhang X; Wang X; Li J
Cancer Biomark; 2017 Jul; 20(1):49-54. PubMed ID: 28759955
[TBL] [Abstract][Full Text] [Related]
14. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition.
Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y
Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728
[TBL] [Abstract][Full Text] [Related]
15. Plasma miR-185 is decreased in patients with esophageal squamous cell carcinoma and might suppress tumor migration and invasion by targeting RAGE.
Jing R; Chen W; Wang H; Ju S; Cong H; Sun B; Jin Q; Chu S; Xu L; Cui M
Am J Physiol Gastrointest Liver Physiol; 2015 Nov; 309(9):G719-29. PubMed ID: 26316588
[TBL] [Abstract][Full Text] [Related]
16. The expression of annexin-A1 in esophageal squamous cell carcinoma and its association with the biological behavior of the primary human esophageal squamous carcinoma cell line.
Li XJ; Li J; Zhang QQ; Su LP; Guo Y; Gong XL; Yao JJ; Wang L; Zhang ZQ
J Physiol Pharmacol; 2023 Oct; 74(5):. PubMed ID: 38085519
[TBL] [Abstract][Full Text] [Related]
17. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
18. Diagnostic and prognostic implications of a serum miRNA panel in oesophageal squamous cell carcinoma.
Wu C; Wang C; Guan X; Liu Y; Li D; Zhou X; Zhang Y; Chen X; Wang J; Zen K; Zhang CY; Zhang C
PLoS One; 2014; 9(3):e92292. PubMed ID: 24651474
[TBL] [Abstract][Full Text] [Related]
19. High expression of long non-coding RNA AFAP1-AS1 predicts chemoradioresistance and poor prognosis in patients with esophageal squamous cell carcinoma treated with definitive chemoradiotherapy.
Zhou XL; Wang WW; Zhu WG; Yu CH; Tao GZ; Wu QQ; Song YQ; Pan P; Tong YS
Mol Carcinog; 2016 Dec; 55(12):2095-2105. PubMed ID: 26756568
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
